SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-21-044118
Filing Date
2021-06-30
Accepted
2021-06-30 19:10:20
Documents
2
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1622
2 POA DOCUMENT poa.txt EX-24.3_996479 3541
  Complete submission text file 0001209191-21-044118.txt   6540
Mailing Address 4435 NORTH FIRST STREET, SUITE 360 LIVERMORE CA 94551
Business Address 4435 NORTH FIRST STREET, SUITE 360 LIVERMORE CA 94551 925-368-8508
Acumen Pharmaceuticals, Inc. (Issuer) CIK: 0001576885 (see all company filings)

IRS No.: 364108129 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O ACUMEN PHARMACEUTICALS, INC. 427 PARK STREET CHARLOTTESVILLE VA 22902
Business Address
Fountain Nathan B (Reporting) CIK: 0001869596 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40551 | Film No.: 211063407